Detection of point mutations at codon 12 of KI-ras in ophthalmic pterygia

Eye

Volumn 19, Issue 2, 2005, Pages 210-214

  Detorakis, E T ^a,b   Zafiropoulos, A ^a   Arvanitis, D A ^a   Spandidos, D A ^a  

^a UNIVERSITY OF CRETE   (Greece)

^b DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

Author keywords

Pterygium ras gene mutation

Indexed keywords

RAS PROTEIN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CODON; CONJUNCTIVA; CONTROLLED STUDY; CORRELATION ANALYSIS; EYE SURGERY; FEMALE; GENE AMPLIFICATION; GENE SEQUENCE; HUMAN; HUMAN TISSUE; MALE; MUTATIONAL ANALYSIS; ONCOGENE H RAS; ONCOGENE N RAS; POINT MUTATION; POLYMERASE CHAIN REACTION; POSTOPERATIVE COMPLICATION; PTERYGIUM; RADIATION EXPOSURE; RECURRENT DISEASE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEQUENCE ANALYSIS; SOLAR RADIATION; VISION;

EID: 14644417889     PISSN: 0950222X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.eye.6701452     Document Type: Article

References (27)

1. Waller SG, Adamis AP. Pterygium. In: Duane's Ophthalmology Vol 6, Chapter 35. Tasman W, Jaeger E (eds). J.B. Lippincott (co): Philadelphia, 1994, pp 1-10.
2. Coroneo MT. Pterygium as an indicator of ultraviolet insulation: a hypothesis. Br J Ophthalmol 1993; 77: 734-739.
3. Taylor HR, West SK, Rosenthal FS, Munoz B, Newland HS, Emmett EA. Corneal changes associated with chronic UV irradiation. Arch Ophthalmol 1989; 107(10): 1481-1484.
4. Detorakis ET, Drakonaki EE, Spandidos DA. Molecular genetic alterations and viral presence in ophthalmic pterygium (Review). Int J Mol Med 2000; 6: 35-41.
5. Detorakis ET, Sourvinos G, Tsamparlakis J, Spandidos DA. Evaluation of loss of heterozygosity and microsatellite instability in human pterygium: clinical correlations. Br J Ophthalmol 1998; 82 1324-1328.
6. Detorakis ET, Sourvinos G, Spandidos DA. Detection of herpes simplex virus and human papilloma virus in ophthalmic pterygium. Cornea 2001; 20: 164-167.
7. Dushku N, Reid TW. P53 expression in altered limbal basal cells of pingueculae, pterygia, and limbal tumors. Curr Eye Res 1997; 16: 1179-1192.
8. Dushku N, Reid TW. Immunohistochemical evidence that human pterygia originate from an invasion of vimentin-expressing altered epithelial basal cells. Curr Eye Res 1994; 13: 473-481.
9. Nishigori C, Wang S, Miyakoshi J, Sato M, Tsukada T, Yagi T et al. Mutations in ras genes in cells cultured from mouse skin tumors induced by ultraviolet irradiation. Proc Natl Acad Sci USA 1994; 19: 7189-7193.
10. Jiveskog S, Ragnarsson-Olding B, Platz A, Ringborg U. N-ras mutations are common in melanomas from sun-exposed skin of humans but rare in mucosal membranes or unexposed skin. J Invest Dermatol 1998; 111: 757-761.
11. El-Shabrawi Y, Radner H, Muellner K, Langmann G, Hoefler G. The role of UV-radiation in the development of conjunctival malignant melanoma. Acta Ophthalmol Scand 1999; 77: 31-32.
12. Mc Pherson MJ, Quirke P, Taylor GR. PCR. A Practical Approach. Oxford University Press: Oxford, 1991.
13. Glarakis IS, Savva S, Spandidos DA. Activation of the ras genes in malignant and premalignant colorectal tumors. Oncol Rep 1998; 5: 1451-1454.
14. Jiang W, Kahn SM, Guillem JG, Lu SH, Weinstein IB. Rapid detection of ras oncogenes in human tumors: applications to colon, esophageal and gastric cancers. Oncogene 1989; 4: 923-928.
15. Koffa M, Malamou-Mitsi V, Agnantis NJ, Spandidos DA. Mutational activation of K-ras oncogene in human breast tumours. Int J Oncol 1994; 4: 573-576.
16. Anderson JA, Irish JC, Ngan BY. Prevalence of RAS oncogene mutation in head and neck cancer. J Otolaryngol 1992; 21: 321-326.
17. Field JK, Spandidos DA. The role of ras and myc oncogenes in human solid tumors and their relevance in diagnosis and prognosis. Anticancer Res 1990; 10: 1-22.
18. Barbacid M. Ras genes. Ann Rev Biochem 1987; 56: 779-827.
19. Takakura A, Miyoshi J, Ishizaki H, Tanaka M, Togawa A, Nishizawa Y et al. Involvement of a small GTP-binding protein (G protein) regulator, small G protein GDP dissociation stimulator, in antiapoptotic cell survival signaling. Mol Biol Cell 2000; 11 1875-1886.
20. Tan DT, Tang WY, Liu YP, Goh HS, Smith DR. Apoptosis and apoptosis related gene expression in normal conjunctiva and pterygium. Br J Ophthalmol 2000; 84: 212-216.
21. Aoki Y, Hosaka S, Tachibana N, Karasawa Y, Kawa S, Kiyosawa K. Reassessment of K-ras mutations at codon 12 by direct PCR and sequencing from tissue microdissection in human pancreatic adenocarcinomas. Pancreas 2000; 21: 152-157.
22. Hilbe W, Dlaska M, Duba HC, Dirnhofer S, Eisterer W, Oberwasserlechner F et al. Automated real-time PCR to determine K-ras codon 12 mutations in non-small cell lung cancer: comparison with immunohistochemistry and clinico-pathological features. Int J Oncol 2003; 23: 1121-1126.
23. Kusaka T, Fukui H, Sano Y, Ueda Y, Chiba T, Fujimori T. Of K-ras codon 12 mutations and p53 overexpression in colorectal nodule-aggregating tumors. J Gastroenterol Hepatol 2000; 15: 1151-1157.
24. Finkelstein SD, Sayegh R, Christensen S, Swalsky PA. Genotypic classification of colorectal adenocarcinoma. Biologic behavior correlates with K-ras-2 mutation type. Cancer 1993; 71: 3827-3838.
25. Al-Mulla F, Going JJ, Sowden ETHH, Winter A, Pickford IR, Birnie GD. Heterogeneity of mutant versus wild-type Ki-ras in primary and metastatic colorectal carcinomas, and association of codon-12 valine with early mortality. J Pathol 1998; 185: 130-138.
26. Yamashita N, Minamoto T, Ochiai A, Onda M, Esumi H. Frequent and characteristic K-ras activation in aberrant crypt foci of colon. Is there preference among K-ras mutants for malignant progression? Cancer 1995; 75 (6 Suppl): 1527-1533.
27. Urban T, Ricci S, Danel C, Antoine M, Kambouchner M, Godard V et al. Detection of codon 12 K-ras mutations in non-neoplastic mucosa from bronchial carina in patients with lung adenocarcinomas. Br J Cancer 2000; 82: 412-417.